IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice - Test2 - elhamkhani - TriplyDB

IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice

IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice

http://www.wikidata.org/entity/Q27008536

about

The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune Response Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis Current Management of Alcoholic Hepatitis and Future Therapies Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis Macrophages and Alcohol-Related Liver Inflammation Alcohol's Effect on Host Defense The Role of Innate Immunity in Alcoholic Liver Disease Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases Update on Alcoholic Hepatitis Inflammasomes in pancreatic physiology and disease Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article Critical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: From Basic Science to Clinical Trials Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis Chronic alcohol consumption potentiates the development of diabetes through pancreatic β-cell dysfunction Alcoholic hepatitis and HCV interactions in the modulation of liver disease Neurotropin suppresses inflammatory cytokine expression and cell death through suppression of NF-κB and JNK in hepatocytes IL-37 inhibits inflammasome activation and disease severity in murine aspergillosis Emerging concepts in alcoholic hepatitis Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.Refining anti-inflammatory therapy strategies for bronchopulmonary dysplasia.Interleukin-1 receptor antagonist expression is inversely associated with outcomes of hepatitis B-related acute-on-chronic liver failure.New drug targets for alcoholic liver disease.Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Screening of surface markers on rat intestinal mucosa microfold cells by using laser capture microdissection combined with protein chip technology.A Mechanistic Review of Cell Death in Alcohol-Induced Liver Injury.New therapeutic targets in alcoholic hepatitis.Integrated Assessment of Diclofenac Biotransformation, Pharmacokinetics, and Omics-Based Toxicity in a Three-Dimensional Human Liver-Immunocompetent Coculture System.Fibrogenesis in alcoholic liver disease.Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical Relevance Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis.Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis.Inhibition of heat shock protein 90 alleviates steatosis and macrophage activation in murine alcoholic liver injury.Hexokinase II binding to mitochondria is necessary for Kupffer cell activation and is potentiated by ethanol exposure Activation of N-methyl-d-aspartate receptor downregulates inflammasome activity and liver inflammation via a β-arrestin-2 pathway Role of Mitochondria in Alcoholic Liver Disease Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.Scropolioside B inhibits IL-1β and cytokines expression through NF-κB and inflammasome NLRP3 pathways.Pathobiology of liver fibrosis: a translational success story

P2860

Q26743383-4DFB9BE7-7151-4671-9FB8-8B7F5D8095E1 Q26744390-1549589B-6E34-4C2F-B757-59648F61ABA5 Q26746544-0A995A00-641D-4D33-9A21-BBA62B8CC78C Q26746997-EEBA7B17-AF56-4BC3-83E0-5E3D4407792C Q26771553-003A31CC-7280-4C57-814C-C87ABF95DB05 Q26773204-1DFE5D03-371E-491E-B4FD-42B8F5F98979 Q26773226-04281945-5055-4504-ACF8-EED8C9706AEC Q26773296-3F28E34E-6289-49B3-B5CF-F2AE790C944C Q26778328-2F335C9A-6577-4AA8-A063-1FDE5656526B Q26779121-B4E5A388-64EB-48D7-9DDC-C372A54269FF Q27027483-B8DAF965-E430-405D-B91F-A6264A5A6D2C Q27027733-5847B783-D639-423C-BD61-BF3962E8984F Q28070168-B6AB0A67-A524-41CE-920F-1E2E9C7EBEFF Q28073542-A1DD6721-41A4-40C8-A217-C8D36BD318BA Q28077079-705E4F3F-BABC-4AFE-8871-BB55D26E54B6 Q28082228-B0A213BF-DD14-457B-B3B5-DE91F4171D0E Q28084063-747CE050-02ED-4738-A56F-7994D13ECA13 Q28542459-7190124B-49BF-45F8-B8E3-749EFB7D67DE Q28544789-7C436A65-E708-4581-842F-A473F24665EE Q30234425-73360826-2CC6-43F3-8ECE-FD605DF29FA2 Q30375693-8E6AD474-76FC-44AD-9CDE-3E51F1DCC3B2 Q33684200-8B611859-5110-48C1-BEAB-2AD14ADE9EA7 Q33744626-3F8D26FC-8CDE-4310-9DAA-AF09F18D4B5C Q33746508-0604C759-691C-4FCC-9D15-D80351B3A8C6 Q33755829-0830A90D-F719-4A66-A30D-7C2EE42C6A3E Q33756249-11591255-C9E0-4E0D-AB2D-C1766D2B7C38 Q33756960-84546A06-FBAC-412D-921F-BEA1C723A075 Q33757267-48B23B81-D521-4414-B127-E88638537C77 Q33792887-4FD8EFCB-13FF-43DF-A1F2-FB36C38E460A Q33845463-83C874E8-C961-4AE9-BBED-DE7E5F897F4C Q33882332-B00B9F29-5508-442E-B76F-5D7AB457F708 Q33903664-2B35B513-4E1E-40B2-870B-868773106D8A Q34214279-78D8E422-CF38-4E95-993D-43D289A8F98D Q34216745-4E166A28-F258-4F67-900C-34402AD7DB8A Q34249104-5EF90BE2-7897-4528-B8BA-1FE63BA2B1AE Q34295408-6EE28F2F-C312-4278-917A-0E93D7DB5177 Q34377243-DC955030-2103-4253-83D2-E46FC35F0BFA Q34404386-5D0BECCE-922D-427B-9CCE-18C9DB454BF7 Q34438283-3967FCC4-E10A-4A53-A8A9-6F6D3AA75035 Q34462733-5E7E4B34-7D03-4A48-A214-06994F5E8060

P2860

IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice

http://www.wikidata.org/entity/Q27008536

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice

@ast

IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice

@en

IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice

@nl

type

label

IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice

@ast

IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice

@en

IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice

@nl

prefLabel

IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice

@ast

IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice

@en

IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice

@nl

P1433

Q27008536-198D1453-1290-4C0E-9D43-526790E3136C

P1476

Q27008536-46A410B1-F271-4125-BE87-D101F4560D29

P2093

Q27008536-163260A0-6284-4E55-B0D2-629A2666A987

Q27008536-2823AAC2-8216-4EAF-B2D6-D1BF57BBE302

Q27008536-31EE14E1-9C8B-440F-91CD-1ABEE2460E1C

Q27008536-542D1F4C-8846-438C-BB6A-37AAFFD5BDAC

Q27008536-659A3D15-FE81-4D8D-B65A-A59C19D937ED

Q27008536-7A00CB2B-8EF6-4077-82C6-DAC4A101E339

Q27008536-7E3EBEA8-E606-4B82-99F7-EEE025F67D22

Q27008536-899C772E-53D6-4C05-89B4-3C1654513089

Q27008536-8EA298B6-AB73-42BC-8BF5-45D87C39B3BA

Q27008536-9C0489BA-6821-477F-8ACA-5FEADFF2FDD6

P2860

Q27008536-06FE247C-EA1B-4AC0-AED4-F425302A82CB

Q27008536-1303EEE7-11B6-4B85-93CF-D6DE883DBB14

Q27008536-147AF779-91B8-457B-97FD-28FE469EC110

Q27008536-1486EAA0-9712-4FD1-8F63-06CE6960C7A3

Q27008536-21B672FB-0E4C-4F07-8F9E-C7BBD6B11E54

Q27008536-2BC8A673-4650-4236-B772-CFDD18C85258

Q27008536-35FDBC09-BC10-4B3B-9D1D-629DED48AFD5

Q27008536-382FCFA5-E5AA-4590-B774-098A9161E5C6

Q27008536-38FA2C34-56B6-45D5-9D94-D9D4DC27DDFC

Q27008536-3A7CD7ED-16C1-4807-A51E-6C0E476AF5AD

P304

Q27008536-C316FCFD-B64E-4439-8848-AFE486BC7AA6

P31

Q27008536-0C537505-FCCF-47F2-A395-B25EA1F6BAF9

P3181

Q27008536-ABC29976-E5D0-4B5E-9185-8BB565DDE23C

P356

Q27008536-004C09CB-2F5C-4119-A6AC-2E0C7B032E5F

P407

Q27008536-9E2925DF-6658-4E28-AEA4-94594DE2257B

P433

Q27008536-CCA52EE5-2B2D-452E-9256-180C2B985595

P478

Q27008536-30393905-F69F-48CC-A66F-A722AE2C6B73

P577

Q27008536-DE112A51-DF34-41E7-91C3-20582D85E724

P698

Q27008536-4305680B-4FA3-459F-9492-D2C5924FE68F

P921

Q27008536-0F0F27DB-9E5C-4B6C-A857-B9ABDE501328

Q27008536-F021A084-720F-4240-B5F7-4F6150B13478

P932

Q27008536-F8AC9913-21A8-455D-BC0F-B5C393075222

P3181

P356

P1433

Journal of Clinical Investigation

P1476

IL-1 receptor antagonist ameli ...... oholic steatohepatitis in mice

@en

P2093

Dora Lippai

http://www.w3.org/2001/XMLSchema#string

Evelyn A. Kurt-Jones

http://www.w3.org/2001/XMLSchema#string

Gyongyi Szabo

http://www.w3.org/2001/XMLSchema#string

Jan Petrasek

http://www.w3.org/2001/XMLSchema#string

Karen Kodys

http://www.w3.org/2001/XMLSchema#string

Matthew Barrieau

http://www.w3.org/2001/XMLSchema#string

Shashi Bala

http://www.w3.org/2001/XMLSchema#string

So-Yun Min

http://www.w3.org/2001/XMLSchema#string

Timea Csak

http://www.w3.org/2001/XMLSchema#string

Victoria Menashy

http://www.w3.org/2001/XMLSchema#string

P2860

Anakinra for rheumatoid arthritis

The inflammasomes

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

Immunological and inflammatory functions of the interleukin-1 family

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials.

Interleukin-1 receptor antagonist modulates the early phase of liver regeneration after partial hepatectomy in mice.

Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease

Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion.

Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells.

P304

3476-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

761308

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI60777

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22945633

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis

P932

3461900

http://www.w3.org/2001/XMLSchema#string